Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Lucid Diagnostics (LUCD) Preferred Shares Issued (2023 - 2024)

Lucid Diagnostics' Preferred Shares Issued history spans 2 years, with the latest figure at $11.6 million for Q2 2024.

  • For Q2 2024, Preferred Shares Issued changed N/A year-over-year to $11.6 million; the TTM value through Dec 2024 reached $29.8 million, up 59.99%, while the annual FY2024 figure was $29.8 million, 59.99% up from the prior year.
  • Preferred Shares Issued reached $11.6 million in Q2 2024 per LUCD's latest filing, down from $18.2 million in the prior quarter.
  • In the past five years, Preferred Shares Issued ranged from a high of $18.2 million in Q1 2024 to a low of $5.0 million in Q4 2023.